Incidence and clinical presentation of invasive neonatal group B streptococcal infections in Germany

被引:85
作者
Fluegge, Kirsten
Siedler, Anette
Heinrich, Beate
Schulte-Moenting, Juergen
Moennig, Maria-Jantje
Bartels, Dorothee B.
Dammann, Olaf
von Kries, Ruediger
Berner, Reinhard
机构
[1] Univ Hosp Freiburg, Dept Pediat & Adolescent Med, D-79106 Freiburg, Germany
[2] Robert Koch Inst, D-1000 Berlin, Germany
[3] Univ Dusseldorf, Childrens Hosp, German Pediat Surveillance Unit Off, D-4000 Dusseldorf, Germany
[4] Univ Freiburg, Dept Biometry & Med Stat, Freiburg, Germany
[5] Hannover Med Sch, Perinatal Infect Dis Epidemiol Unit, Dept Obstet, D-3000 Hannover, Germany
[6] Hannover Med Sch, Dept Pediat, D-3000 Hannover, Germany
[7] Childrens Hosp, Dept Neurol, Boston, MA 02115 USA
[8] Harvard Univ, Sch Med, Boston, MA 02115 USA
[9] Univ Munich, Inst Social Pediat & Adolescent Med, Munich, Germany
关键词
Streptococcus agalactiae; incidence; invasive; neonatal; Germany;
D O I
10.1542/peds.2005-2481
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
OBJECTIVE. Streptococcus agalactiae (group B Streptococcus) is an important cause of morbidity and mortality in newborn infants. So far, there have been no published data on the incidence, morbidity, and mortality of invasive neonatal group B Streptococcus infections in Germany. METHODS. A prospective active surveillance study involving all of the pediatric hospitals, which reported their cases to the German Pediatric Surveillance Unit, and all of the microbiological laboratories serving pediatric hospitals, which reported their cases to the Laboratory Sentinel Group at Robert Koch Institute Berlin, was conducted between 2001 and 2003. Capture-recapture analysis was used to evaluate the completeness of reported neonatal invasive group B Streptococcus infections. RESULTS. We collected and analyzed data from 347 and 360 infants with invasive group B Streptococcus infection during the first 3 months of life, as reported by pediatricians to the German Pediatric Surveillance Unit and microbiologists to the Robert Koch Institute Berlin, respectively. Using capture-recapture analysis, we calculated an incidence of 0.47 per 1000 live births. Nearly 60% of the infants suffered from early-onset disease, and 16% of these presented with meningitis. In contrast, 61.8% of infants with late-onset disease presented with meningitis. Prematurity was present in 22.4% of early-onset disease and 39.7% of late-onset disease cases, respectively. A high proportion of infants suffered from sequelae because of group B Streptococcus infection at the time of discharge from the hospital. Most common sequelae were hydrocephalus and cerebral seizure. Case fatality rate was 4.3%. CONCLUSIONS. This study, which is the first to provide information on the current national incidence and morbidity of invasive group B Streptococcus infection in Germany, demonstrates remarkable country-specific variation in comparison with other European countries, which gather data in a similar fashion. Therefore, the importance of country-specific prevention guidelines has to be stressed.
引用
收藏
页码:E1139 / E1145
页数:7
相关论文
共 50 条
  • [21] Invasive Group B Streptococcal Disease in Nonpregnant Adults
    M. Bolaños
    A. Cañas
    O. Santana
    J. Pérez-Arellano
    I. de Miguel
    A. Martín-Sánchez
    European Journal of Clinical Microbiology & Infectious Diseases, 2001, 20 : 837 - 839
  • [22] Recurrent Group B Streptococcus Neonatal Invasive Infections, France, 2007-2021
    Sbaa, Ghalia
    Delettre, Nicolas
    Guyonnet, Cecile
    Le Huu Nghia, Sebastien
    Joubrel-Guyot, Caroline
    Plainvert, Celine
    Poyart, Claire
    Tazi, Asmaa
    JOURNAL OF INFECTIOUS DISEASES, 2024, 231 (02) : 329 - 333
  • [23] Invasive group A streptococcal infections in adults, France (2006-2010)
    Plainvert, C.
    Doloy, A.
    Loubinoux, J.
    Lepoutre, A.
    Collobert, G.
    Touak, G.
    Trieu-Cuot, P.
    Bouvet, A.
    Poyart, C.
    CLINICAL MICROBIOLOGY AND INFECTION, 2012, 18 (07) : 702 - 710
  • [24] Changes in the incidence and epidemiology of neonatal group B Streptococcal disease over the last two decades in Crete, Greece
    Vergadi, Eleni
    Manoura, Antonia
    Chatzakis, Emmanouil
    Karavitakis, Emmanouil
    Maraki, Sofia
    Galanakis, Emmanouil
    INFECTIOUS DISEASE REPORTS, 2018, 10 (03) : 56 - 59
  • [25] RELAPSING INVASIVE GROUP-B STREPTOCOCCAL INFECTION IN ADULTS
    HARRISON, LH
    ALI, A
    DWYER, DM
    LIBONATI, JP
    REEVES, MW
    ELLIOTT, JA
    BILLMANN, L
    LASHKERWALA, T
    JOHNSON, JA
    ANNALS OF INTERNAL MEDICINE, 1995, 123 (06) : 421 - 427
  • [26] INCIDENCE AND OUTCOME OF GROUP B STREPTOCOCCAL SEPSIS IN INFANTS IN SWITZERLAND
    Giannoni, Eric
    Berger, Christoph
    Stocker, Martin
    Agyeman, Philipp
    Posfay-Barbe, Klara M.
    Heininger, Ulrich
    Konetzny, Gabriel
    Niederer-Loher, Anita
    Kahlert, Christian
    Donas, Alex
    Leone, Antonio
    Hasters, Paul
    Relly, Christa
    Baer, Walter
    Aebi, Christoph
    Schlapbach, Luregn J.
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2016, 35 (02) : 222 - 224
  • [27] Are Invasive Group A Streptococcal Infections Preventable by Antibiotic Therapy?: A Collaborative Retrospective Study
    Erlacher, Rahel
    Toepfner, Nicole
    Dressen, Svenja
    Berner, Reinhard
    Boesch, Annemarie
    Tenenbaum, Tobias
    Heininger, Ulrich
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2024, 43 (10) : 931 - 935
  • [28] Epidemiology of an upsurge of invasive group A streptococcal infections in Ireland, 2012-2015
    Meehan, Mary
    Murchan, Stephen
    Gavin, Patrick J.
    Drew, Richard J.
    Cunney, Robert
    JOURNAL OF INFECTION, 2018, 77 (03) : 183 - 190
  • [29] Neonatal group B streptococcal disease: from pathogenesis to preventive strategies
    Melin, P.
    CLINICAL MICROBIOLOGY AND INFECTION, 2011, 17 (09) : 1294 - 1303
  • [30] Reductions in neonatal listeriosis: "Collateral benefit" of Group B streptococcal prophylaxis?
    Lee, Brian
    Newland, Jason G.
    Jhaveri, Ravi
    JOURNAL OF INFECTION, 2016, 72 (03) : 317 - 323